Stephen Ray Mitchell - 14 Nov 2024 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: Director
Signature: /s/ Stephen Ray Mitchell
Issuer symbol: VNDA
Transactions as of: 14 Nov 2024
Net transactions value: -$25,863
Form type: 4
Filing time: 18 Nov 2024, 17:45:50 UTC
Previous filing: 21 May 2024
Next filing: 09 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Sale	$25,863	-5,000	-10%	$5.17	44,857	14 Nov 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.15 to $5.195, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.15 to $5.195, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.